Approximately 200,000 patients over the age of 65 undergo gallbladder surgery every year. Unfortunately, one in four patients will suffer from a perioperative complication due to the risk of general anesthesia, resulting in a $500M USD impact to the US healthcare system every year.
At Ictero Medical, we are developing the CholeSafe System, the first minimally invasive treatment option that helps decrease complications and costs while providing definitive therapy to high risk surgical patients with gallstone disease. Unlike laparoscopic cholecystectomy, the CholeSafe System can be used in the interventional radiology suite with only minimal local anesthesia to defunctionalize the gallbladder without having to remove it. This allows providers to give their patients the benefits of surgery, without the risk.